- Home
- TOMZ vs THAR Comparison
TOMZ vs THAR Comparison
Compare TOMZ & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- THAR
- Stock Information
- Founded
- TOMZ 1979
- THAR 2017
- Country
- TOMZ United States
- THAR United States
- Employees
- TOMZ N/A
- THAR N/A
- Industry
- TOMZ Diversified Commercial Services
- THAR Biotechnology: Pharmaceutical Preparations
- Sector
- TOMZ Finance
- THAR Health Care
- Exchange
- TOMZ Nasdaq
- THAR Nasdaq
- Market Cap
- TOMZ 20.3M
- THAR 22.8M
- IPO Year
- TOMZ N/A
- THAR 2022
- Fundamental
- Price
- TOMZ $0.85
- THAR $4.23
- Analyst Decision
- TOMZ Strong Buy
- THAR Strong Buy
- Analyst Count
- TOMZ 1
- THAR 1
- Target Price
- TOMZ $3.50
- THAR $17.00
- AVG Volume (30 Days)
- TOMZ 33.9K
- THAR 3.2M
- Earning Date
- TOMZ 11-07-2025
- THAR 11-07-2025
- Dividend Yield
- TOMZ N/A
- THAR N/A
- EPS Growth
- TOMZ N/A
- THAR N/A
- EPS
- TOMZ N/A
- THAR N/A
- Revenue
- TOMZ $6,219,036.00
- THAR N/A
- Revenue This Year
- TOMZ $18.31
- THAR N/A
- Revenue Next Year
- TOMZ $103.30
- THAR N/A
- P/E Ratio
- TOMZ N/A
- THAR N/A
- Revenue Growth
- TOMZ N/A
- THAR N/A
- 52 Week Low
- TOMZ $0.63
- THAR $0.95
- 52 Week High
- TOMZ $1.50
- THAR $9.08
- Technical
- Relative Strength Index (RSI)
- TOMZ 37.32
- THAR 69.41
- Support Level
- TOMZ $0.88
- THAR $2.85
- Resistance Level
- TOMZ $0.95
- THAR $4.52
- Average True Range (ATR)
- TOMZ 0.06
- THAR 0.69
- MACD
- TOMZ -0.01
- THAR 0.14
- Stochastic Oscillator
- TOMZ 0.04
- THAR 35.51
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.